Compare RCS & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RCS | KRMD |
|---|---|---|
| Founded | 1994 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 284.6M | 272.8M |
| IPO Year | N/A | N/A |
| Metric | RCS | KRMD |
|---|---|---|
| Price | $5.78 | $5.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 141.1K | ★ 141.8K |
| Earning Date | 01-01-0001 | 03-11-2026 |
| Dividend Yield | ★ 10.12% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $39,070,637.00 |
| Revenue This Year | N/A | $24.15 |
| Revenue Next Year | N/A | $18.41 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 22.12 |
| 52 Week Low | $4.51 | $1.86 |
| 52 Week High | $6.31 | $6.61 |
| Indicator | RCS | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 33.42 | 43.94 |
| Support Level | $6.04 | $5.56 |
| Resistance Level | $6.15 | $5.83 |
| Average True Range (ATR) | 0.13 | 0.30 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 5.45 | 38.55 |
PIMCO Strategic Income Fund, Inc. operates as a closed-end management investment company. Its primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities. The Fund also seeks capital appreciation to the extent consistent with the objective.
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).